Clinical Trials
20
Trial Phases
3 Phases
Drug Approvals
2
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (20 trials with phase data)β’ Click on a phase to view related trials
Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- First Posted Date
- 2013-08-05
- Last Posted Date
- 2015-06-29
- Lead Sponsor
- Meda Pharmaceuticals
- Target Recruit Count
- 348
- Registration Number
- NCT01915823
- Locations
- πΊπΈ
Clinical Research Center of Alabama,LLC, Birmingham, Alabama, United States
πΊπΈLittle Rock Allergy and Asthma Clinical research Center, Little Rock, Alaska, United States
πΊπΈClinical Research Atlanta, Atlanta, Georgia, United States
Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to <6 Years With AR
- Conditions
- Allergic Rhinitis
- Interventions
- Drug: 205.5 mcg of azelastine hydrochlorideDrug: 137 mcg of azelastine hydrochloride
- First Posted Date
- 2013-06-19
- Last Posted Date
- 2015-06-29
- Lead Sponsor
- Meda Pharmaceuticals
- Target Recruit Count
- 191
- Registration Number
- NCT01880840
- Locations
- πΊπΈ
Clinical Research Center of Alabama,LLC, Birmingham, Alabama, United States
πΊπΈLittle Rock Allergy and Asthma Clinical research Center, Little Rock, Alaska, United States
πΊπΈWest Coast Clinical Trials, Costa Mesa, California, United States
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
- Conditions
- Allergic Rhinitis
- Interventions
- First Posted Date
- 2013-02-20
- Last Posted Date
- 2015-03-31
- Lead Sponsor
- Meda Pharmaceuticals
- Target Recruit Count
- 405
- Registration Number
- NCT01794741
- Locations
- πΊπΈ
Clinical Research Center of Alabama,LLC, Birmingham, Alabama, United States
πΊπΈLittle Rock Allergy and Asthma Clinical research Center, Little Rock, Alaska, United States
πΊπΈWest Coast Clinical Trials, Costa Mesa, California, United States
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
- Conditions
- Herpes Labialis
- Interventions
- Drug: acyclovir/hydrocortisone cream
- First Posted Date
- 2012-04-10
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- Meda Pharmaceuticals
- Target Recruit Count
- 54
- Registration Number
- NCT01574612
- Locations
- πΊπΈ
MCS Clinical Trials, Los Angeles, California, United States
πΊπΈSunshine Research Center, Opa-Locka, Florida, United States
πΊπΈAltus Rsearch,INC, West Palm Beach, Florida, United States
A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Seasonal Allergies
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- First Posted Date
- 2011-06-08
- Last Posted Date
- 2011-10-06
- Lead Sponsor
- Meda Pharmaceuticals
- Target Recruit Count
- 617
- Registration Number
- NCT01368445
- Locations
- πΊπΈ
AABI Associates Medical Group, Fountain Valley, California, United States
πΊπΈWest Coast Clinical Trials, Long Beach, California, United States
πΊπΈAllergy Research Foundation, Los Angeles, California, United States
- Prev
- 1
- 2
- 3
- 4
- Next